Marcin Drąg

Dr. Marcin Drąg

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
MDMarcin Drąg
Marcin Drąg
GSGuy Salvesen
Guy Salvesen

16 October 2020 in Science Advances
Verified
Journal Article
Open access
PDF file
WRWioletta Rut
Wioletta Rut
ZLZongyang Lv
Zongyang Lv
MZMikolaj Zmudzinski
Mikolaj Zmudzinski
SPStephanie Patchett
Stephanie Patchett
DNDigant Nayak
Digant Nayak
SOShaun K. Olsen
Shaun K. Olsen
A multidisciplinary approach yields novel inhibitors and reveals substrate specificity, structure, and mechanisms of CoV-2 PLpro.

22 October 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
WRWioletta Rut
Wioletta Rut
KGKatarzyna Groborz
Katarzyna Groborz
LZLinlin Zhang
Linlin Zhang
XSXinyuanyuan Sun
Xinyuanyuan Sun
MZMikolaj Zmudzinski
Mikolaj Zmudzinski
MDMarcin Drąg
Marcin Drąg

3 February 2014 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PKPaulina Kasperkiewicz
Paulina Kasperkiewicz
MPMarcin Poreba
Marcin Poreba
SSScott J. Snipas
Scott J. Snipas
HPHeather Parker
Heather Parker
CWChristine C. Winterbourn
Christine C. Winterbourn
MDMarcin Drąg
Marcin Drąg
Significance: The exploration of protease substrate specificity is generally restricted to naturally occurring amino acids, limiting the degree of conformational space that can be surveyed. We substantially enhanced this by incorporating 102 unnatural amino acids to explore the S1–S4 pockets of human neutrophil elastase. This approach provides hybrid natural and unnatural amino acid sequences, and thus we termed it the Hybrid Combinatorial Substrate Library. Using this approach, we have designed an extremely active substrate of NE and subsequently converted it into an ultrasensitive activity-based probe for imaging active elastase during the process of neutrophil extracellular trap formation. Our study could have a substantial effect on the design of substrates, inhibitors, and probes for any endopeptidase.

1 February 2021 in Vaccines
Verified
Journal Article
Open access
PDF file
Piotr RzymskiPiotr Rzymski
Piotr Rzymski
LBLeszek Borkowski
Leszek Borkowski
MDMarcin Drąg
Marcin Drąg
Robert FlisiakRobert Flisiak
Robert Flisiak
JJJacek Jemielity
Jacek Jemielity
AFAndrzej Fal
Andrzej Fal
COVID-19 vaccinations are about to begin in various countries or are already ongoing. This is an unprecedented operation that is also met with a loud response from anti-vaccine communities—currently using all available channels to manipulate public opinion. At the same time, the strategy to educate on vaccinations, explain their mechanism of action, and build trust in science is subdued in different world parts. Such actions should go much beyond campaigns promoting the COVID-19 vaccines solely on the information provided by the health institutions and national authorities. In this paper, actions provided by independent expert groups needed to counteract the anti-vaccine propaganda and provide scientific-based information to the general public are offered. These actions encompass organizing groups continuously communicating science on COVID-19 vaccines to the general public; tracking and tackling emerging and circulating fake news; and equipping celebrities and politicians with scientific information to ensure the quality of messages they communicate, as well as public letters, and statements of support for vaccination by healthcare workers, recognized scientists, VIPs, and scientific societies; and no tolerance to false and manipulated claims on vaccination spread via traditional and social media as well as by health professionals, scientists, and academics. These activities should be promptly implemented worldwide, regardless of the current status and availability of the COVID-19 vaccine in a particular region. If we are about to control the pandemic for the sake of public benefit, it is high time to collectively speak out as academic and medical societies with support from decision-makers. Otherwise, the battle will be lost to those who stand against scientific evidence while offering no feasible solution to the problem.

9 October 2021 in Cell Reports
Verified
Journal Article
Open access
IPIsabel Pablos
Isabel Pablos
YMYoan Machado
Yoan Machado
HJHugo C. Ramos de Jesus
Hugo C. Ramos de Jesus
YMYasir Mohamud
Yasir Mohamud
RKReinhild Kappelhoff
Reinhild Kappelhoff
COChris Overall
Chris Overall
The main viral protease (3CLpro) is indispensable for SARS-CoV-2 replication. We delineate the human protein substrate landscape of 3CLpro by TAILS substrate-targeted N-terminomics. We identify more than 100 substrates in human lung and kidney cells supported by analyses of SARS-CoV-2-infected cells. Enzyme kinetics and molecular docking simulations of 3CLpro engaging substrates reveal how noncanonical cleavage sites, which diverge from SARS-CoV, guide substrate specificity. Cleaving the interactors of essential effector proteins, effectively stranding them from their binding partners, amplifies the consequences of proteolysis. We show that 3CLpro targets the Hippo pathway, including inactivation of MAP4K5, and key effectors of transcription, mRNA processing, and translation. We demonstrate that Spike glycoprotein directly binds galectin-8, with galectin-8 cleavage disengaging CALCOCO2/NDP52 to decouple antiviral-autophagy. Indeed, in post-mortem COVID-19 lung samples, NDP52 rarely colocalizes with galectin-8, unlike in healthy lungs. The 3CLpro substrate degradome establishes a foundational substrate atlas to accelerate exploration of SARS-CoV-2 pathology and drug design.